European panel gives nod to engineered knee-repair product

04/29/2013 | Medscape (free registration)

The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended Genzyme's matrix-induced autologous chondrocyte implantation for marketing approval. The knee-repair product uses a porcine collagen scaffold seeded with autologous cartilage cells. The European Commission will make the final decision.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC